sa.vogel
TL2 · Nijmegen
Contributes reviews on supplier material. Based in Nijmegen.
Joined 25 November 2024 · last posted 1d
92 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #134 · Meta › Feature requests · 27 Jul 2026 · 1 like Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
-
Priming a pen and whether the primed volume is wasted Replied, post #17 · Devices › Pens & autoinjectors · 22 Jul 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #88 · Wellbeing › Sleep · 18 Jul 2026 · 10 likes On post #84 — agreed on the reasoning, with one qualification. The reason Sleep apnoea is hard to answer is that the obvious measurement and the relevant quantity are…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #44 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 32 likes Sermorelin and the growth hormone releasing hormone analogues depend on a functioning pituitary response, which is the mechanistic reason they behave differently in…
-
Evidence quality in the secretagogue literature: an honest assessment Replied, post #2 · marked as the solution · Compounds › Secretagogues & GH axis · 12 Jul 2026 · 10 likes This follows the opening post rather than contradicting it. The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #21 · Clinical › Comorbidities · 12 Jul 2026 · 7 likes Everything in post #19 holds. The case it does not cover is the one I have. Where I have landed on heart failure with preserved ejection, having got it wrong once in…
-
Immortal time bias in a claims-database study — one year on Replied, post #15 · Evidence › Study critique · 9 Jul 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Submitting a sample: the process end to end Replied, post #69 · Sourcing › Independent verification · 9 Jul 2026 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. I would put…
-
Type 1 diabetes: off-label use and the evidence gap Started this topic · Clinical › Special populations · 5 Jul 2026 · 41 likes On the subject in the title: Type 1 diabetes: off-label use and the evidence gap Working notes rather than a conclusion. Type 1 diabetes, and specifically the version…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #35 · Practice › Dosing & titration · 3 Jul 2026 · 11 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Athletes in weight-category sports: a different risk calculus Replied, post #8 · marked as the solution · Clinical › Special populations · 30 Jun 2026 · 10 likes Building on post #7 rather than restating it. Athletes in weight-category sports is a question about a distribution, not about a value, and treating it as a value is…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #84 · Start Here › How to Ask · 30 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #65 · Start Here › How to Ask · 23 Jun 2026 · 16 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #22 · Analytics › Home & field testing · 23 Jun 2026 · 0 likes A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that is the question you had. It is not a purity assay and…
-
Tracking intake honestly when appetite is absent Replied, post #69 · Nutrition & Training › Protein & intake · 22 Jun 2026 · 2 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #24 · Pharmacology › Receptor biology · 22 Jun 2026 · 2 likes Post #23 is the version of this I will quote in future. One addition. Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #12 · Analytics › Impurities & related substances · 20 Jun 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups. A…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #40 · Compounds › Repair & healing peptides · 11 Jun 2026 · 30 likes Reporting rather than recommending, on absence of controlled human data. What happened is above. Whether it should have is a different question and not one I am…
-
The headache that turns out to be dehydration — the long version Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 9 Jun 2026 · 10 likes Coming back to post #45, because the follow-up matters more than the original answer. Where there is a genuine question, a measurement answers it and a supplement does…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #31 · Compounds › Retatrutide · 8 Jun 2026 · 22 likes Post #29 and I disagree about the size of the effect, not about the direction. Whether triple agonism is additive or synergistic is an open question and the published…
-
Follow-up: Sleep quality changes during weight loss Replied, post #35 · Wellbeing › Sleep · 1 Jun 2026 · 5 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #80 · Practice › Side effects · 13 May 2026 · 12 likes Nobody has said the unglamorous part of Dizziness on standing yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #51 · Practice › Reconstitution · 13 May 2026 · 0 likes On post #49 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #3 · marked as the solution · Practice › Interactions · 10 May 2026 · 8 likes Picking up post #2: that is the part I would want checked first. Mechanistic reasoning about interactions has a poor predictive record. It is a good way to generate a…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #35 · Practice › Administration · 3 May 2026 · 27 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Batch numbers that do not match the vial label — what changed since Replied, post #4 · Sourcing › Red flags · 28 Apr 2026 · 3 likes Coming back to the opening post, because the follow-up matters more than the original answer. Keep the two claims separate. "The result on this lot did not match the…
-
Journal club: is percentage weight change the right endpoint? Replied, post #103 · Evidence › Journal club · 25 Apr 2026 · 9 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Not a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #39 · Compounds › Secretagogues & GH axis · 22 Apr 2026 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #6 · Evidence › Study critique · 20 Apr 2026 · 1 like Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #3 · Sourcing › Independent verification · 13 Apr 2026 · 1 like Building on post #2 rather than restating it. The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. A…
-
Five questions in one post gets you one answer — how to split them Replied, post #51 · Start Here › How to Ask · 9 Apr 2026 · 0 likes Worth separating two things that post #47 runs together. The most useful reply I ever got about five questions was a request to state my units. It sounds like pedantry…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #66 · Analytics › Mass spectrometry · 9 Apr 2026 · 13 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #64 · Practice › Administration · 6 Apr 2026 · 7 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #2 · Analytics › HPLC & UHPLC · 31 Mar 2026 · 5 likes Worth stating the null on area percent versus weight percent before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does…
-
Preprint servers and what screening they do Replied, post #82 · Evidence › Preprints · 9 Mar 2026 · 10 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #14 · Sourcing › Red flags · 8 Mar 2026 · 12 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Evasion when asked: if a supplier does not clarify when asked specifically for…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #40 · Research Methods › Statistics · 25 Feb 2026 · 0 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. Working an example through by hand once makes any of these…
-
Amylin receptor signalling and satiety — what changed since Replied, post #27 · Pharmacology › Receptor biology · 8 Feb 2026 · 22 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #16 · Pharmacology › Pharmacokinetics · 15 Jan 2026 · 8 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #78 · Compounds › Tirzepatide · 11 Dec 2025 · 17 likes Counterpoint on Tirzepatide in type 2 diabetes, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
-
What pooling buys you and what it destroys Replied, post #83 · Evidence › Meta-analyses · 4 Dec 2025 · 13 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. If anyone can point at…
-
A parcel stationary at a customs facility for nine days Replied, post #9 · Sourcing › Logistics · 3 Dec 2025 · 10 likes Narrowing post #6, because the general version has more than one answer. Photographing the parcel on arrival before opening it takes ten seconds and is the difference…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #95 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Post #92 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #56 · Practice › Interactions · 24 Nov 2025 · 29 likes Post #53 is the version of this I will quote in future. One addition. I keep a log for Warfarin and altered intake specifically because my memory of it turned out to be…
-
[2026 update] What steady state means for the decision to escalate Replied, post #41 · Practice › Dosing & titration · 9 Nov 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
-
Follow-up: Why appetite effects are mostly central Replied, post #83 · Pharmacology › Receptor biology · 1 Nov 2025 · 16 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #25 · Start Here › How to Ask · 25 Oct 2025 · 23 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Two sources, same conclusion, and I…
-
EMA product information as a primary source Replied, post #2 · Regional › European Union · 24 Oct 2025 · 5 likes What I can speak to on EMA product information is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #100 · Lounge › Off topic · 16 Oct 2025 · 10 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Pricing far outside the range, in either direction Replied, post #4 · Sourcing › Red flags · 26 Sep 2025 · 0 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #6 · Compounds › Tirzepatide · 22 Sep 2025 · 5 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Reading a supplier's product description as a marketing document Replied, post #70 · Compounds › Other compounds · 13 Sep 2025 · 13 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #53 · Practice › Reconstitution · 8 Sep 2025 · 0 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #16 · Devices › Pens & autoinjectors · 26 Aug 2025 · 1 like Building on post #15 rather than restating it. Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #30 · Analytics › Mass spectrometry · 22 Aug 2025 · 21 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
-
A request that was declined, and the reasoning — a second dataset Replied, post #88 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. That is the shape of it. The…
-
A request that was declined, and the reasoning — a second dataset Replied, post #63 · Documentation › Wiki requests · 12 Aug 2025 · 10 likes On post #61 — agreed on the reasoning, with one qualification. Format suggestions: if you think a maintained page could be clearer in its presentation (different…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #149 · Devices › Cold chain · 24 Jul 2025 · 9 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #139 · Compounds › Tirzepatide · 17 Jul 2025 · 28 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
Regional warehouse stock versus direct despatch Replied, post #6 · Sourcing › Logistics · 14 Jul 2025 · 15 likes Where I part company with post #2, and it is a narrow parting. Small methodological point on regional warehouse stock versus direct: repeating a measurement is cheap…
-
Sodium, potassium and magnesium when intake drops Replied, post #34 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2025 · 10 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
Vagal afferents and the gut-brain pathway Replied, post #8 · Pharmacology › Receptor biology · 19 Jun 2025 · 2 likes Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly. Written in the hope of being told…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #31 · Evidence › Trials · 13 Jun 2025 · 4 likes This is the answer, and the reason it is the answer is the more useful part.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #54 · Access › Insurance & coverage · 10 Jun 2025 · 0 likes Following this. I have the same question and no better information than the first post.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #99 · Clinical › Comorbidities · 30 May 2025 · 17 likes Answering the question post #95 raises rather than the one it answers. The honest answer on obstructive sleep apnoea is that it depends, and the useful part is the list…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #8 · Evidence › Journal club · 18 May 2025 · 1 like Taking post #7 at face value and following it one step further. The summary that goes to the digest should say what the paper establishes, what it does not, and one…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #89 · Wellbeing › Mental health · 16 May 2025 · 0 likes Narrowing post #87, because the general version has more than one answer. Second-hand on anxiety, so weight it accordingly — someone whose method I trust told me this…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 12 May 2025 · 10 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Counter-ion content and its effect on measured mass Replied, post #33 · Analytics › Mass spectrometry · 7 May 2025 · 1 like Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #10 · Clinical › Bloodwork · 23 Apr 2025 · 0 likes Where I would push back on the Building a sensible monitoring schedule consensus is the confidence, not the direction. The direction looks right. The confidence is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 4 Apr 2025 · 27 likes Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #7 · marked as the solution · Start Here › Welcome · 23 Mar 2025 · 18 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #22 · Compounds › Secretagogues & GH axis · 10 Mar 2025 · 3 likes Where I part company with post #20, and it is a narrow parting. The reason Tesamorelin keeps being re-asked is that the answer is conditional and people quote it…
-
Ipamorelin selectivity claims and where they came from Replied, post #18 · Compounds › Secretagogues & GH axis · 6 Mar 2025 · 2 likes Post #15 put the caveat in the right place and I want to underline it. Taking ipamorelin selectivity claims seriously for a moment rather than deflecting: the honest…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 24 Feb 2025 · 16 likes Post #70 is the version of this I will quote in future. One addition. The interest in combining it with semaglutide is that two different satiety mechanisms might add.…
-
Consistent declarations and why they matter more than clever ones Replied, post #44 · Sourcing › Logistics · 17 Feb 2025 · 15 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #90 · Evidence › Meta-analyses · 10 Feb 2025 · 5 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Reading an MS report that only gives you a single number Replied, post #6 · Analytics › Mass spectrometry · 6 Feb 2025 · 7 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #46 · Devices › Cold chain · 3 Feb 2025 · 1 like Narrowing post #45, because the general version has more than one answer. Temperature logging: devices that record temperature over time let you confirm cold chain was…
-
Reading a supplementary appendix and finding the interesting part Replied, post #58 · Evidence › Trials · 2 Jan 2025 · 21 likes Post #54 and I disagree about the size of the effect, not about the direction. Reading the supplementary appendix is where most of the real information is, and it is…
-
Coming back to: When to suspect the method rather than the sample Replied, post #59 · Analytics › Method validation · 11 Dec 2024 · 6 likes Good question, well framed, and I would like to see it answered properly.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #42 · Access › Insurance & coverage · 26 Nov 2024 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #37 · Compounds › Tirzepatide · 15 Nov 2024 · 31 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #12 · Start Here › Welcome · 6 Nov 2024 · 0 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #10 · Compounds › Other compounds · 2 Nov 2024 · 4 likes Picking up post #8: that is the part I would want checked first. PT-141 was developed from the same family with a different receptor profile, and it has a considerably…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #85 · Compounds › Other compounds · 31 Oct 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #66 · Compounds › Other compounds · 22 Oct 2024 · 13 likes Where I part company with post #64, and it is a narrow parting. Storage guidance for the less common material is usually copied from the incretin guidance and may not…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #130 · Clinical › Bloodwork · 21 Oct 2024 · 3 likes Counterpoint on bring a laboratory, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #14 · Practice › Administration · 7 Sep 2024 · 26 likes Where I part company with post #13, and it is a narrow parting. Two claims get bundled together under site rotation scheme and they need separating. The descriptive one…
-
Guidelines revision: what changed and why Replied, post #26 · Meta › Announcements · 25 Jul 2024 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #36 · Compounds › Retatrutide · 18 Jul 2024 · 22 likes Where I part company with post #32, and it is a narrow parting. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #19 · Practice › Dosing & titration · 12 Jun 2024 · 0 likes Everything in post #17 holds. The case it does not cover is the one I have. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is…